Literature DB >> 18723231

Muscle sympathetic nerve activity in patients with Chagas' disease.

Carlos E Negrão1, Amilton C Santos, Maria U Rondon, Fabio G Franco, Barbara Ianni, Carlos E Rochitte, Ana M F W Braga, Múcio T Oliveira, Charles Mady, Antonio C P Barretto, Holly R Middlekauff.   

Abstract

BACKGROUND: The progression of heart failure in Chagas' disease has been explained by remodeling, leading to neurohumoral activation, or by the direct parasite damage to parasympathetic neurons during acute phase, leading to early sympathetic activation and progressive heart failure. To help distinguish between these hypotheses we studied muscle sympathetic nerve activity (MSNA) at rest and during handgrip exercise (30% of maximal voluntary contraction) in patients with Chagas' disease and normal ejection fraction vs. patients with heart failure.
METHODS: A consecutive study of 72 eligible out-patients/subjects was conducted between July 1998 and November 2004. The participants were classified in three advanced heart failure groups (New York Heart Association Functional Classes II-III): Chagas' disease (n=15), ischemic (n=15) and idiopathic cardiomyopathy (n=15). Twelve Chagas' disease patients without heart failure and normal ejection fraction, and 15 normal controls were also studied. MSNA was recorded directly from the peroneal nerve by microneurography technique.
RESULTS: MSNA was greater in heart failure patients when compared with Chagas' disease patients without heart failure (51+/-3 vs. 20+/-2 bursts/min P=0.0001). MSNA in Chagas' patients with normal ejection fraction and normal controls was not different. During exercise, MSNA was similar in all 3 heart failure groups. And, was lower in the Chagas' patients with normal ejection fraction than in patients with Chagas' disease and heart failure (28+/-1 vs. 63+/-5 bursts/min, respectively).
CONCLUSION: MSNA is not elevated in patients with Chagas' disease with normal ejection fraction. These findings support the concept of remodeling and neurohumoral activation as a common pathway following significant cardiac injury.

Entities:  

Mesh:

Year:  2008        PMID: 18723231     DOI: 10.1016/j.ijcard.2008.06.093

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Effects of exercise training on neurovascular control and skeletal myopathy in systolic heart failure.

Authors:  Carlos E Negrao; Holly R Middlekauff; Igor L Gomes-Santos; Ligia M Antunes-Correa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

2.  Impact of gender on benefits of exercise training on sympathetic nerve activity and muscle blood flow in heart failure.

Authors:  Ligia M Antunes-Correa; Ruth C Melo; Thais S Nobre; Linda M Ueno; Fabio G M Franco; Ana M W Braga; Maria U P B Rondon; Patricia C Brum; Antonio C P Barretto; Holly R Middlekauff; Carlos E Negrao
Journal:  Eur J Heart Fail       Date:  2010-01       Impact factor: 15.534

3.  Predictors of low cardiac output in decompensated severe heart failure.

Authors:  Marcelo Eidi Ochiai; Juliano Novaes Cardoso; Kelly Regina Novaes Vieira; Marcelo Villaça Lima; Euler Cristovan Ochiai Brancalhao; Antonio Carlos Pereira Barretto
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  Cardiac autonomic control mechanisms in the pathogenesis of chagas' heart disease.

Authors:  Diego F Dávila; Jose H Donis; Gabriela Arata de Bellabarba; Vanesa Villarroel; Francisco Sanchez; Lisbeth Berrueta; Siham Salmen; Barbara Das Neves
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-02

5.  Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies.

Authors:  Guilherme Wesley Peixoto da Fonseca; Tania Garfias Macedo; Nicole Ebner; Marcelo Rodrigues Dos Santos; Francis Ribeiro de Souza; Charles Mady; Liliam Takayama; Rosa Maria Rodrigues Pereira; Wolfram Doehner; Stefan D Anker; Carlos Eduardo Negrão; Maria Janieire de Nazaré Nunes Alves; Stephan von Haehling
Journal:  ESC Heart Fail       Date:  2020-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.